Treatable traits can be identified in a severe asthma registry and predict future exacerbations
- 19 September 2018
- journal article
- research article
- Published by Wiley in Respirology
- Vol. 24 (1) , 37-47
Abstract
Background and objective: A new taxonomic and management approach, termed treatable traits, has been proposed for airway diseases including severe asthma. This study examined whether treatable traits could be identified using registry data and whether particular treatable traits were associated with future exacerbation risk.Methods: The Australasian Severe Asthma Web‐Based Database (SAWD) enrolled 434 participants with severe asthma and a comparison group of 102 participants with non‐severe asthma. Published treatable traits were mapped to registry data fields and their prevalence was described. Participants were characterized at baseline and every 6 months for 24 months.Results: In SAWD, 24 treatable traits were identified in three domains: pulmonary, extrapulmonary and behavioural/risk factors. Patients with severe asthma expressed more pulmonary and extrapulmonary treatable traits than non‐severe asthma. Allergic sensitization, upper‐airway disease, airflow limitation, eosinophilic inflammation and frequent exacerbations were common in severe asthma. Ten traits predicted exacerbation risk; among the strongest were being prone to exacerbations, depression, inhaler device polypharmacy, vocal cord dysfunction and obstructive sleep apnoea.Conclusion: Treatable traits can be assessed using a severe asthma registry. In severe asthma, patients express more treatable traits than non‐severe asthma. Traits may be associated with future asthma exacerbation risk demonstrating the clinical utility of assessing treatable traits.Keywords
Funding Information
- AstraZeneca
- Boehringer Ingelheim
- GlaxoSmithKline
- Novartis
- Roche
This publication has 23 references indexed in Scilit:
- Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?Thorax, 2013
- The COPD control panel: towards personalised medicine in COPDThorax, 2012
- Exacerbations of severe asthmaClinical & Experimental Allergy, 2012
- Multidimensional assessment of older people with asthma and COPD: clinical management and health statusAge and Ageing, 2010
- Refractory asthma in the UK: cross-sectional findings from a UK multicentre registryThorax, 2010
- Measurement properties and interpretation of three shortened versions of the asthma control questionnaireRespiratory Medicine, 2005
- The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthmaEuropean Respiratory Journal, 2003
- Predictors of therapy resistant asthma: outcome of a systematic evaluation protocolThorax, 2003
- Bayesian model averaging: a tutorial (with comments by M. Clyde, David Draper and E. I. George, and a rejoinder by the authorsStatistical Science, 1999
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983